OPKO Health's subsidiary, BioReference, repaid about $9.7 million to terminate a credit agreement and completed the sale of its laboratory testing business for approximately $237.5 million in cash on September 16, 2024.
AI Assistant
OPKO HEALTH INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.